Clinical Trial Update: A First in Human Study for the Versa Device for Tricuspid Regurgitation [NA]

View source ↗

Summary

First-in-human testing of Versa Device for treating tricuspid regurgitation; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Regurgitation

Drugs mentioned

• Versa Device

Snippet

Sponsor: Versa Vascular, Inc | Conditions: Tricuspid Regurgitation | NA | Status: ACTIVE_NOT_RECRUITING